Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Frazier Life Sciences raises $1.3B for early-stage biotech fund
Frazier Life Sciences gathered an impressive $1.3 billion in capital commitments for its 12th venture fund aimed at private early-stage biotechs.
James Waldron
Jul 31, 2025 7:54am
Fierce Biotech Fundraising Tracker: Artbio, MapLight & more
Jul 29, 2025 10:15am
Radiopharma biotech Artbio paints path to clinic with $132M
Jul 29, 2025 7:30am
BMS hands 5 autoimmune drugs to Bain-backed spinout
Jul 29, 2025 5:08am
MapLight raises $373M to plot phase 2 journey for Cobenfy rival
Jul 28, 2025 10:23am
Leads Biolabs hits Hong Kong stock exchange in $189M IPO
Jul 25, 2025 10:59am
